<code id='DF62D7852F'></code><style id='DF62D7852F'></style>
    • <acronym id='DF62D7852F'></acronym>
      <center id='DF62D7852F'><center id='DF62D7852F'><tfoot id='DF62D7852F'></tfoot></center><abbr id='DF62D7852F'><dir id='DF62D7852F'><tfoot id='DF62D7852F'></tfoot><noframes id='DF62D7852F'>

    • <optgroup id='DF62D7852F'><strike id='DF62D7852F'><sup id='DF62D7852F'></sup></strike><code id='DF62D7852F'></code></optgroup>
        1. <b id='DF62D7852F'><label id='DF62D7852F'><select id='DF62D7852F'><dt id='DF62D7852F'><span id='DF62D7852F'></span></dt></select></label></b><u id='DF62D7852F'></u>
          <i id='DF62D7852F'><strike id='DF62D7852F'><tt id='DF62D7852F'><pre id='DF62D7852F'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:6531
          The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus
          Summa Health

          General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

          The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

          advertisement

          On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Genentech weighs delaying cancer therapy after drug pricing law
          Genentech weighs delaying cancer therapy after drug pricing law

          GenentechCEOAlexanderHardyGenentechWASHINGTON—PlentyofpharmaceuticalexecutiveshavedecriedDemocrats’n

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

          1:30Aboywalksthroughafloodedareainal-SagainorthofOmdurmanonAugust6,2023.Torrentialrainshavedestroyed